Existence. . Loss And Alisertib

Материал из Wiki портал КГАУ "КЦИОКО"
Перейти к: навигация, поиск

Breast Cancers Ers 2007,8(Only two):R23.PubMedCrossRef GSK J4 in vivo 20. Mullins Mirielle, Perreard L, Quackenbush JF, Gauthier And, Bayer Ersus, Ellis Meters, Parker T, Perou Centimeters, Szabo A, Bernard Ps3: Contract within breast cancers category among microarray and quantitative opposite transcribing PCR coming from fresh-frozen along with formalin-fixed, paraffin-embedded flesh. Clin Chem 07,Fifty three(Seven):1273�C1279.PubMedCrossRef Nineteen. Nielsen In order to, Hsu FD, Jensen E, Cheang Meters, Karaca H, Hu Z, Hernandez-Boussard Capital t, Livasy D, Cowan N, Dressler D, et ing.: Immunohistochemical along with clinical portrayal from the basal-like subtype associated with obtrusive breast carcinoma. Clin Cancer Res 2004,15(Of sixteen):5367�C5374.PubMedCrossRef 30. Morrison DH, Rahardja Deb, Master Elizabeth, Peng Y simply, Sarode VR: Tumour biomarker expression comparative Alisertib in order to age group and also molecular subtypes of obtrusive cancers of the breast. Br M Cancers 2012. Twenty one. Caudle While, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo Are, Hoffman E, Meric-Bernstam F, Look KK, Buchholz TA, avec al.: Local-regional handle according to surrogate indicators involving cancer of the breast subtypes along with response to neoadjuvant radiation within breast cancer sufferers undergoing busts preserving treatment. Breast cancers Ers 2012,18(Three):R83.PubMedCrossRef Twenty-two. Martin Mirielle, Rodriguez-Lescure A new, Ruiz The, Alba Elizabeth, Calvo L, Ruiz-Borrego Meters, Munarriz T, Rodriguez Florida, Crespo Chemical, de Alava At the, et aussi ing.: Randomized stage Three or more trial of fluorouracil, epirubicin, and also cyclophosphamide on it's own as well as accompanied by Paclitaxel with regard to earlier breast cancer. L Natl Cancer Inst 2009,A hundred(11):805�C814.PubMedCrossRef Twenty three. Allred Digicam, Harvey JM, Berardo M, Clark GM: Prognostic and also predictive elements in cancer of the breast by simply immunohistochemical investigation. Contemporary Pathol Before 2000,12(Two):155�C168. All day and. Wolff Air conditioning, Hammond Us, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett Meters, Fitzgibbons PL, Hanna WM, Langer The, et aussi 's.: United states Modern society associated with Scientific Oncology/College of yank Pathologists guide tips for human skin progress aspect receptor Only two screening in cancers of the breast. M Clin Oncol 07,Twenty-five(One particular):118�C145.PubMedCrossRef CP673451 25. Eisen Megabytes, Spellman Rehabilitation, Dark brown PO, Botstein Deb: Bunch analysis as well as show involving genome-wide phrase designs. Proc Natl Acad Sci You Utes The 98,89(Twenty five):14863�C14868.PubMedCrossRef 25. Ebbert MT, Bastien Three quarter's, Boucher Kilometers, Martin Michael, Carrasco Elizabeth, Caballero Third, Stijleman IJ, Bernard Ps3, Facelli JC: Portrayal involving doubt within the classification of multivariate assays: program for you to PAM50 centroid-based genomic predictors for breast cancers treatment programs. J Clin Bioinforma This year, A single:Thirty seven.PubMedCrossRef Twenty-seven. Liu B, Hayes DN, Nobel Any, Marron JS: Mathematical Significance of Clustering regarding High-Dimension, Low-Sample Measurement Data. M Am Statistic Assoc '08,103(483):1281�C1293.CrossRef 31. Elloumi F ree p, Hu Z, Li Ful, Parker JS, Gulley Milliliter, Amos KD, Troester Mummy: Systematic Opinion throughout Genomic Category Because of Contaminating Non-neoplastic Muscle inside Busts Cancer Biological materials.